Search
for
Sort by
Research 391–420 of 1000+
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- The rationale for physiological testosterone replacement in women
- Changes of androgens levels in menopausal women
- Hormonal therapies for acne
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women
- Hormone therapy in acne
- Hormonal Parameters in Androgenetic Hair Loss in the Male
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Postmenopausal virilization after spousal use of topical androgens
- What is the Rationale for Androgen Therapy for Women?
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- CLINICAL UPDATES IN HAIR
- Skin and glucocorticoids: effects of local skin glucocorticoid impairment on skin homeostasis
- Ovarian morphology is associated with insulin resistance in women with polycystic ovary syndrome: a cross sectional study
- Congenital adrenal hyperplasia
- Urinary steroids in women with androgenic alopecia
- The Effect of Alfacalcidiol and Metformin on Phenotype Manifestations in Women with Polycystic Ovary Syndrome – a Preliminary Study
- Alopecia - the search for novel agents continues
- Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
- Endocrine disorders and hormonal therapy for adolescent acne
- Influence of sex and functional status on the value of serum steroid profiling in discriminating adrenocortical carcinoma from adrenocortical adenoma
- A 5α-reductase inhibitor, finasteride, increases differentiation and proliferation of embryonal carcinoma cell-derived-neural cells
- Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
- Urinary 5-ene-steroid excretion in non-classical congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency (NC-3BHSD)
- Study of Cutaneous Manifestations of Polycystic Ovarian Syndrome
- Reversal of andro-genetic alopecia in a male. A spironolactone effect?
- Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
- CONTRACEPTION AND THE SKIN